The highlight of the recent MedAdvisor (ASX:MDR) annual results for FY 2018 was undoubtedly the fact that revenue from continuing operations reached $6.6 million, some 50% higher than last year. To the company’s credit, they highlighted this operational number as well as the more flattering $7.4 million in revenue, once you include R&D grants. It made a statutory loss of $4.5 million.

Community-based healthcare roll-up, Zenitas Healthcare Ltd (ASX:ZNT), released its results as well as news of a takeover proposal on Friday in chaotic fashion. The stock went into a trading halt before the market opened amid reports of an offer to acquire the company in the Australian Financial Review. It then traded in two short intervals following the release of its annual report but prior to confirmation of the takeover bid. Anyone who sold their shares during these periods would be pretty angry given the stock was trading around 10% to 15% higher following the crucial news. The ASX should reverse all trades that took place before the offer was announced.

Author: Fabregasto

MNF Group (ASX:MNF) yesterday released its results for FY 2018. Unfortunately for shareholders, they were the least pleasing results I have witnessed from this company. Fortunately, the long term investment thesis remains in place.

Vale Mike King -- I wish you lived to see this 10-bagger (for you). So many spiffy pops for you my friend.

Provider of systems and services for air traffic control (ATC) training and air traffic management (ATM), Adacel Technologies Limited (ASX:ADA) released its results for FY 2018 on Thursday night.

Disinfection specialist Nanosonics (ASX:NAN) has delivered an 11% drop in sales and a 60% decline in pre-tax profit for the full year ending June 30, 2018. That’s a big decline, but these headline numbers mask what’s really going on.

As a developer, operator and owner of wind farms, Windlab Ltd (ASX:WND) is at the forefront of the transition towards renewable energy. So how does Windlab stack up as an investment?

The tutoring company Kip McGrath (ASX: KME) released its results on Friday showing a continuing implementation of its long term strategy. It’s steady as she goes.